Gyre Therapeutics Inc. Dividends
The next dividend date for Gyre Therapeutics Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Gyre Therapeutics Inc. (GYRE)
| 01/13/2023 | 12/27/2022 | 01/05/2023 | 01/12/2023 | $3.60 |
| 09/21/2022 | 08/25/2022 | 09/06/2022 | 09/20/2022 | $21.45 |
| 08/20/2015 | 08/04/2015 | 08/14/2015 | 08/19/2015 | $896.18 |
More About Gyre Therapeutics Inc.
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573, which is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Owning Gyre Therapeutics Inc. Stock on the Dividend Date
If you own Gyre Therapeutics Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Gyre Therapeutics Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Gyre Therapeutics Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Gyre Therapeutics Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Gyre Therapeutics Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Gyre Therapeutics Inc. Dividends
You can contact us any time if you would like to ask questions about Gyre Therapeutics Inc. dividends or anything else related to the stock market.